The Scientist

» immunotherapy

Most Recent

image: <em>The Scientist</em> on the Pulse, April 23

The Scientist on the Pulse, April 23

By Kerry Grens | April 23, 2015

Hot topics in cancer research from the annual meeting of the American Association for Cancer Research

0 Comments

T-cell receptor repertoires could help researchers determine whether a certain treatment will work for a given cancer patient. 

0 Comments

image: HIV Antibody Therapy

HIV Antibody Therapy

By Jef Akst | April 8, 2015

Delivering antibodies to HIV-infected people can lower levels of the virus, a study shows.

0 Comments

image: Another CAR-T IPO

Another CAR-T IPO

By Jef Akst | April 6, 2015

Cellectis goes public for a whopping $228 million—nearly double the value the company filed for in February.

0 Comments

image: Personalized Cancer Vaccines

Personalized Cancer Vaccines

By Anna Azvolinsky | April 2, 2015

A dendritic cell vaccine targeting melanoma patients’ tumor-specific mutations can activate a broad range of cancer-fighting T cells. 

2 Comments

image: Cancer Immunotherapist

Cancer Immunotherapist

By Jef Akst | April 1, 2015

Scientist to Watch Yvonne Saenger explains recent advances in using biomarkers to identify cancer patients who might benefit most from immunotherapy.

1 Comment

image: The CAR T-Cell Race

The CAR T-Cell Race

By Vicki Brower | April 1, 2015

Tumor-targeting T-cell therapies are generating remarkable remissions in hard-to-beat cancers—and attracting millions of dollars of investment along the way.

2 Comments

image: Yvonne Saenger: Immunotherapy Pioneer

Yvonne Saenger: Immunotherapy Pioneer

By Jef Akst | April 1, 2015

Assistant Professor, Department of Medicine, Columbia University. Age: 41

5 Comments

image: Opinion: Making Cancer Vaccines Work

Opinion: Making Cancer Vaccines Work

By Abhishek Srivastava and Haval Shirwan | March 31, 2015

Armed with the right adjuvant system, vaccines are poised to tackle one of the world’s most intractable diseases. 

4 Comments

image: Long-Lived Immunotherapy Stem Cells

Long-Lived Immunotherapy Stem Cells

By Ruth Williams | February 4, 2015

Genetically modified T memory stem cells persist in patients for more than 10 years, and can differentiate into a variety of T cell types.

1 Comment

Popular Now

  1. How to Separate the Science From the (Jerk) Scientist
  2. Could a Dose of Sunshine Make You Smarter?
  3. Sweden Cancels Agreement With Elsevier Over Open Access
  4. Prevalent Form of Childhood Leukemia May Be Preventable